SCID-hu mice: a model for studying disseminated HIV infection
- PMID: 8883145
- DOI: 10.1006/smim.1996.0028
SCID-hu mice: a model for studying disseminated HIV infection
Abstract
Modifications that we introduced into the implantation of human fetal thymus and liver into SCID mice (thy/liv-SCID-hu mice) markedly increased the population of human T cells and monocytes present in the peripheral blood and peripheral lymphoid compartment of these mice. As a result, the modified thy/liv-SCID-hu mice developed disseminated HIV infection after intraimplant or i.p. inoculation. After chronic HIV infection of these mice, depletion of the peripheral human T cells was observed as reported in HIV-infected individuals. In addition, these mice also developed plasma viremia after infection with HIV. The peripheral blood mononuclear cells were responsive to in-vivo cytokine regulation as evidenced by induction of human IFN-gamma gene expression by human IL-12 and inhibition by human IL-10. Acute treatment with human IL-10 but not with human IL-12 inhibited the development of plasma viremia and HIV infection in thy/liv-SCID-hu mice inoculated with HIV-1(59), a clinical isolate. SCID mice transplanted with cultured human fetal bone marrow displayed significant engraftment of the mouse bone marrow with human precursor cells and population of the peripheral blood with human B cells and monocytes. The peripheral blood of these bone marrow-transplanted SCID mice also became populated with human T cells after they were implanted with human thymic tissue due to migration of human precursor cells from the mouse bone marrow to the implanted human thymus. Thus, these modified SCID-hu mice should prove to be a valuable in-vivo model for studying the immunopathogenesis of HIV infection and for examining the in-vivo efficacy of immunomodulatory, drug and gene therapy in modifying HIV infection.
Similar articles
-
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.J Immunol. 1995 Jan 15;154(2):907-21. J Immunol. 1995. PMID: 7814892
-
The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.J Immunol. 1995 Jun 15;154(12):6612-23. J Immunol. 1995. PMID: 7759895
-
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.J Exp Med. 1994 Feb 1;179(2):513-22. doi: 10.1084/jem.179.2.513. J Exp Med. 1994. PMID: 8294863 Free PMC article.
-
Human T-and B-cell functions in SCID-hu mice.Semin Immunol. 1996 Aug;8(4):207-13. doi: 10.1006/smim.1996.0026. Semin Immunol. 1996. PMID: 8883143 Review.
-
Development and applications of the SCID-hu mouse model.Semin Immunol. 1996 Aug;8(4):187-96. doi: 10.1006/smim.1996.0024. Semin Immunol. 1996. PMID: 8883141 Review.
Cited by
-
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.PLoS Med. 2006 Nov;3(11):e427. doi: 10.1371/journal.pmed.0030427. PLoS Med. 2006. PMID: 17090209 Free PMC article.
-
Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function.J Clin Immunol. 2005 Sep;25(5):462-72. doi: 10.1007/s10875-005-5635-4. J Clin Immunol. 2005. PMID: 16160915
-
The utilization of humanized mouse models for the study of human retroviral infections.Retrovirology. 2009 Aug 12;6:76. doi: 10.1186/1742-4690-6-76. Retrovirology. 2009. PMID: 19674458 Free PMC article. Review.
-
Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1.PLoS One. 2012;7(6):e38853. doi: 10.1371/journal.pone.0038853. Epub 2012 Jun 13. PLoS One. 2012. PMID: 22719966 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials